Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
| Autor: | FIELD, J. J.1,2, FENSKE, T. S.3, BLINDER, M. A.1,2 blinder@labmed.wustl.edu |
|---|---|
| Zdroj: | Haemophilia. Jan2007, Vol. 13 Issue 1, p46-50. 5p. 2 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|